An Official Website of the United States Government
Company Information:
Name:
LYPRO BIOSCIENCES, INC.
Address:
LYPRO BIOSCIENCES, INC.
1236 Hawthorne Street
Alameda, CA
1236 Hawthorne Street
Alameda, CA
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Inhalable amphotericin B nanodisk therapy for pulmonary aspergillosis
Award Year / Program / Phase:
2005 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Trudy M. Forte
Award Amount:
$100,000.00
Abstract:
DESCRIPTION (provided by applicant): Aspergillus fumigatus is an opportunistic pathogenic fungus that predominantly infects immunocompromised patients. It is the most common cause of infectious pneumonic mortality in HIV patients, organ transplant recipients, and cancer patients. Treatment is… More
NanoDisk-Amphotericin B therapy for aspergillosis
Award Year / Program / Phase:
2007 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Trudy M. Forte
Award Amount:
$827,430.00
Abstract:
DESCRIPTION (provided by applicant): Aspergillus fumigatus is an opportunistic pathogenic fungus that predominantly infects immunocompromised patients. It is the most common cause of infectious pneumonic mortality in HIV patients, organ transplant recipie
nts, and cancer patients. A. fumigatus… More
Nanobiotechnology for the Treatment of Mantle Cell Lymphoma
Award Year / Program / Phase:
2009 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Trudy M. Forte
Award Amount:
$109,354.00
Abstract:
DESCRIPTION (provided by applicant): Mantle cell lymphoma (MCL) is a B-cell malignancy that is characterized by dysregulation of various oncogenes. Building on evidence that retinoic acid and its derivative, all trans retinoic acid (ATRA), are useful agent
s that potentiate apoptosis or… More
NanoDisk-Amphotericin B therapy for aspergillosis
Award Year / Program / Phase:
2010 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Trudy M. Forte
Award Amount:
$1,471,851.00
Abstract:
DESCRIPTION (provided by applicant): Aspergillus fumigatus is an opportunistic pathogenic fungus that predominantly infects immunocompromised patients. It is the most common cause of infectious pneumonic mortality in HIV patients, organ transplant recipients, and cancer patients. A. fumigatus… More